Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 185.45B | 185.23B | 213.67B | 240.86B | 154.71B | 112.38B |
Gross Profit | 29.99B | 28.11B | 47.39B | 54.05B | 21.65B | -534.61M |
EBITDA | 28.62B | 25.11B | 42.89B | 29.37B | 27.82B | -7.46B |
Net Income | 609.55M | 382.83M | 15.50B | -2.48B | 7.42B | -21.54B |
Balance Sheet | ||||||
Total Assets | 284.74B | 282.23B | 280.29B | 288.12B | 287.27B | 267.65B |
Cash, Cash Equivalents and Short-Term Investments | 35.31B | 34.52B | 28.59B | 29.77B | 30.96B | 29.53B |
Total Debt | 74.98B | 71.55B | 63.08B | 55.49B | 69.79B | 81.93B |
Total Liabilities | 204.96B | 203.91B | 194.80B | 205.13B | 196.83B | 182.09B |
Stockholders Equity | 59.24B | 59.25B | 70.28B | 67.55B | 75.46B | 71.25B |
Cash Flow | ||||||
Free Cash Flow | 8.59B | 12.00B | 17.75B | 28.86B | 12.72B | -144.00M |
Operating Cash Flow | 23.29B | 27.30B | 32.04B | 40.93B | 23.61B | 12.16B |
Investing Cash Flow | -12.18B | -13.25B | -14.87B | -13.71B | -5.69B | -7.86B |
Financing Cash Flow | -10.93B | -7.30B | -13.36B | -28.02B | -18.08B | 3.96B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | £1.75B | 11.83 | 17.50% | 5.68% | -9.80% | -1.98% | |
78 Outperform | £1.48B | 13.41 | 7.92% | 3.80% | 118.04% | 65.66% | |
73 Outperform | £157.78B | 15.58 | 7.54% | 3.98% | -8.55% | -22.62% | |
71 Outperform | £3.86B | 21.62 | -11.32% | 7.64% | 123.03% | ― | |
65 Neutral | $15.26B | 7.31 | 3.02% | 5.32% | 4.27% | -62.52% | |
63 Neutral | £65.63B | 162.87 | 0.82% | 5.72% | -9.96% | -92.38% | |
61 Neutral | £3.65B | 15.84 | -7.04% | 11.46% | 31.96% | -159.27% |